In May 1997, the Advisory Committee for HIV and STD Prevention (ACHSP) reviewed data on the relation between curable sexually transmitted diseases (STDs) and the risk for sexual transmission of human immunodeficiency virus (HIV). ACHSP considered that the evidence was strong that early detection and treatment of other STDs is an effective strategy for preventing sexually transmitted HIV infection but was concerned that this strategy has not been clearly articulated or implemented as a core strategy for HIV prevention in the United States. In the context of persistently high prevalence of STDs in many parts of the United States and with emerging evidence that the U.S. epidemic of HIV infection and acquired immunodeficiency syndrome (AIDS) increasingly is affecting population groups with the highest rates of curable STDs, ACHSP recommends the following actions: Early detection and treatment of curable STDs should become a major, explicit component of comprehensive HIV prevention programs at national, state, and local levels. In areas where STDS that facilitate HIV transmission are prevalent, screening and treatment programs should be expanded. HIV and STD prevention programs in the United States, together with private and public sector partners, should take joint responsibility for implementing this strategy.

The following CDC staff members prepared this report: Michael E. St. Louis, William C. Levine, Judith N. Wasserheit, Division of STD Prevention Kevin M. DeCock, Division of HIV/AIDS Prevention, Surveillance, and Epidemiology; Gary R. West,. David R. Holtgrave, Division of HIV/AIDS Prevention, Intervention, Research and Support; Ronald O. Valdiserri, Office of the Director, National Center for HIV, STD, and TB Prevention.

9701544

Guidelines and Recommendations
Stephen B. Thacker CDC Library collection